Federal Circuit Strikes Down D.C. Pharmaceutical Law

Law360, New York (August 2, 2007, 12:00 AM EDT) -- A District of Columbia law that regulates the prices of patented drugs was struck down Wednesday by an appellate court, which ruled that the law is superseded by the federal government's exclusive power to legislate patents.

A three-judge panel of the U.S. Court of Appeals for the Federal Circuit, upholding a district court's ruling, ruled that federal patent law preempts the D.C. ordinance. The court cited the clause in the eighth section of Article I of the U.S. Constitution that grants, it said, sole authority over...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.